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Abstract The insulin-responsive glucose transporter, Glut4,
exhibits a unique subcellular distribution such that in the absence
of insulin s95% of the protein is stored within intracellular
membranes. In response to insulin, Glut4 exhibits a large
mobilisation to the plasma membrane. Studies of the amino acid
motifs which regulate the unique trafficking of Glut4 have
identified several key residues within the soluble cytoplasmic N-
and C-terminal domains of Glut4. Of particular note is a Leu-
498Leu-499 motif within the C-terminal domain that has been
proposed to regulate both internalisation from the plasma
membrane and sorting to an insulin-sensitive compartment. In
this study, we have examined the role of the adjacent amino acids
(Glu-491, Gln-492 and Glu-493) by their sequential replacement
with Ala. Our results are consistent with the notion that Glu-491
and Glu-493 play an important role in the sub-endosomal
trafficking of Glut4, as substitution of these residues with Ala
results in increased levels of these proteins at the cell surface,
reduced insulin-stimulated translocation and increased suscept-
ibility to endosomal ablation. These residues, together with other
identified sequences within the C-terminus of Glut4, are likely to
be crucial targeting elements that regulate Glut4 subcellular
distribution. ß 2000 Federation of European Biochemical So-
cieties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Insulin stimulates glucose transport in peripheral tissues by
inducing the movement (‘translocation’) of a pool of intra-
cellular Glut4-containing vesicles to the plasma membrane
[1^3]. In the absence of insulin, Glut4 is distributed among
elements of the endosomal system and the trans-Golgi net-
work (TGN), and also in a system of tubulo-vesicular ele-
ments throughout the cytosol [4^9]. Studies from several lab-
oratories have provided evidence in favour of a slowly
recycling pool of Glut4 that is selectively mobilised to the
plasma membrane in response to insulin (reviewed in [1,2]).
Whether this represents a unique modi¢cation of the existing
endosomal system or, as we and others have argued, a distinct
population of ‘secretory’ vesicles (termed Glut4 storage
vesicles, or GSVs) remains unclear. What is evident, however,
is that Glut4 exhibits slow continuous recycling between intra-
cellular compartment(s) and the plasma membrane [1^3].
Studies aimed at identifying the amino acid sequences that
regulate the unique subcellular distribution of Glut4 have re-
vealed the presence of two internalisation motifs within the
cytosolic domains of Glut4: a Phe-5-based motif in the N-
terminus and a Leu-498Leu-499 pair in the C-terminus [10^
14]. Replacement of either of these motifs with alanine re-
sulted in an accumulation of Glut4 at the plasma membrane
and reduced rates of endocytosis of the expressed Glut4, pro-
viding good evidence that these motifs are involved in the
internalisation of Glut4 from the cell surface [10^14]. How-
ever, there remains some debate regarding whether either or
both of these regions are involved in the targeting of Glut4 to
the slowly recycling compartment/GSVs. However, we and
others have further suggested that these distinct motifs may
also regulate the tra⁄cking within the endosomal system, and
have proposed that Phe-5 and Leu-498Leu-499 may regulate
Glut4 tra⁄cking either through the TGN or control £ux
through the slowly recycling pathway [12].
The presence of distinct sorting signals within membrane
proteins has been shown to regulate their distribution within
the endosomal system [15,16]. Many of these putative signals
bind to coat proteins that are proposed to selectively mediate
the transport of membrane proteins from one compartment to
another [17,18]. Thus, the presence of multiple and distinct
sorting signals within the cytosolic tails of proteins with com-
plex tra⁄cking itineraries is likely required to facilitate their
interaction with di¡erent adapter protein sub-units at multiple
sites throughout the cell. Moreover, the same sorting signal
has been proposed to function at multiple points in the sorting
itinerary (see for example [19]). Hence, further re¢nement of
the precise signals involved in Glut4 tra⁄cking is required. It
has been suggested that the C-terminus of GLUT4 contains
additional targeting information, based on analyses of chimer-
ic transporter proteins expressed in insulin-responsive cells
[11,14,20]. Consequently, we have examined the role of the
C-terminus immediately distal to the LeuLeu motif in Glut4
tra⁄cking in insulin-sensitive 3T3-L1 adipocytes.
In this ??study, we have examined the role of the adjacent
amino acids immediately distal to the LeuLeu motif (Glu-491,
Gln-492 and Glu-493) by their sequential replacement with
alanine. Substitution of Glut-491 or Glu-493 resulted in in-
creased levels of these proteins at the cell surface, reduced
insulin-stimulated translocation and increased susceptibility
to endosomal ablation. Mutation of Gln492 to alanine was
without signi¢cant e¡ect. These data suggest that residues
adjacent to the LeuLeu motif may either regulate the function
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of this motif, or constitute a hitherto unidenti¢ed motif in-
volved in the subcellular tra⁄cking of Glut4.
2. Materials and methods
2.1. Cell culture
3T3-L1 murine ¢broblasts obtained from the American Type Cul-
ture Collection (Rockville, MD, USA). Fibroblasts were induced to
di¡erentiate 2 days after reaching con£uence as described [9,11], ex-
cept that insulin was used at 4 Wg/ml. Cells were used between days 8
and 12 after induction of di¡erentiation.
2.2. Antibodies
The anti-peptide polyclonal antibodies speci¢c for either the 12
COOH-terminal residues of GLUT4 or the 14 COOH-terminal resi-
dues of human GLUT3 have been characterised and described else-
where [11,21]. Dr Morris Birnbaum (University of Pennsylvania) gen-
erously provided the a⁄nity-puri¢ed polyclonal rabbit antiserum
generated against the cytosolic domain of the insulin-regulated amino-
peptidase vp165/IRAP.
2.3. Construction of recombinant GLUT4 transporter cDNAs
The COOH-terminal epitope-tagged GLUT4 mutant was provided
by Professor David E. James (University of Queensland) and has been
previously described and characterised [11]. This mutant employed the
C-terminal 14 amino acids of the human GLUT3 glucose transporter
as an epitope tag, allowing its identi¢cation using an anti-Glut3 anti-
body. The indicated amino acid residues were mutated using the
QuickChange kit (Stratagene, UK), and all mutants were completely
sequenced prior to analysis.
2.4. Expression of GLUT4 mutants in 3T3-L1 adipocytes
cDNA constructs sub-cloned into the pcDNA3 vector (Invitrogen)
were transfected into sub-con£uent 3T3-L1 ¢broblasts using the Cal-
cium Phosphate Transfection kits (Invitrogen, UK) following the
manufacturer’s protocol. Neomycin-resistant colonies (0.8 mg/ml
G418) were isolated and selected as described previously [11,22].
2.5. Di¡erential centrifugation
Subcellular membrane fractions were prepared from basal and in-
sulin-treated adipocytes by di¡erential centrifugation using a protocol
previously described in detail [11,23]. This protocol yields four mem-
brane fractions designated as high density microsomes (HDM), low
density microsomes (LDM), plasma membranes (PM) and mitochon-
dria/nuclei (M/N). Here we have focused on the PM and LDM frac-
tions because these fractions are enriched in cell surface markers and
membranes encompassing intracellular GLUT4, respectively [11,23].
2.6. Preparation and use of HRP-conjugated transferrin
The transferrin-horseradish peroxidase (Tf-HRP) conjugate was
prepared and used exactly as described previously [24]. Cells were
used for ablation experiments 8^12 days post di¡erentiation. Human
apo-transferrin and all reagents for Tf-HRP synthesis were from Sig-
ma (UK). 125I-labelled transferrin and 125I-labelled goat anti-rabbit
antibodies were from Du Pont/NEN (UK). Cells were loaded with
Tf-HRP for the times shown to allow the endosomal system to be-
come loaded. Thereafter, cells were rapidly chilled, cell surface-at-
tached Tf-HRP removed and the cells processed for diaminobenzidine
(DAB) cytochemistry. In brief, duplicate plates were incubated with
DAB and hydrogen peroxide was added to one of the plates to initiate
a cross-linking reaction catalysed by the Tf-HRP in the endosomal
compartment. The plate to which no peroxide was added serves as a
control for comparative purposes. By comparison of cells incubated
with or without peroxide, the localisation of proteins within the endo-
somal compartment can be determined (see [24] for full details).
2.7. Electrophoresis and immunoblotting
Total cell membranes or subcellular membrane fractions (10 Wg
total protein) were subjected to SDS^PAGE using 7.5% or 10% poly-
acrylamide resolving gels and transferred to nitrocellulose. The pro-
tein concentrations of membrane fractions were determined using the
bicinchoninic acid assay (Pierce, USA). Primary antibodies were de-
tected by probing with either HRP-conjugated donkey anti-rabbit or
sheep anti-mouse secondary antibodies using the ECL system (Amer-
sham, UK; Pierce, USA) or 125I-labelled goat anti-rabbit IgG (Du-
Pont/NEN, UK). Autoradiograms were quanti¢ed using a Bio-Rad
densitometer.
2.8. Plasma membrane lawn assays for GLUT or IRAP translocation
After experimental manipulations, coverslips of adipocytes were
rapidly washed in ice-cold bu¡er for the preparation of plasma mem-
brane lawns exactly as described [25]. Triplicate coverslips were pre-
pared at each experimental condition, and 5^10 random images of
plasma membrane lawns collected from each in which plasma mem-
brane lawns were stained with and-Glut3 (1:25) or anti-IRAP (1:250).
These were quanti¢ed using MetaMorph (Universal Imaging, West
Chester, PA, USA) software as described in [25].
3. Results
The sequence of the C-terminal cytosolic domain of Glut4
is shown in Table 1. We have generated three mutations with-
in the region to produce mutant transporters designated AQE,
Table 1
Sequence of the Glut4 C-terminus and the position of the mutated
residues
Shown is the sequence of the wild-type Glut4 C-terminus, the addi-
tion of the Glut3 epitope tag in italics (TAG) and the position of
the three mutants examined in this study in bold.
Fig. 1. Expression levels of the mutant Glut4 species. 25 Wg of total
membranes from clones expressing the indicated mutants were ana-
lysed by immunoblotting with anti-Glut3 antibodies to detect the re-
combinant protein. Shown in A are representative immunoblots
from the clones employed in this study, which are quanti¢ed in B.
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EAE or EQA as shown (Table 1). These mutants, together
with wild-type epitope-tagged Glut4 (TAG), were expressed in
3T3-L1 adipocytes and stable clones selected. Fig. 1 compares
the total levels of expression of epitope-tagged Glut4 in the
cell lines chosen for analysis in this study. For each of the
mutants, we have performed an analysis of the subcellular
distribution of the mutant Glut4 in multiple clonal cell lines
in order to avoid any clonal variability, but show here only
the data relating to the clones shown in Fig. 1. Note that the
level of expression of AQE, EAE and EQA in the clones
Fig. 2. Subcellular distribution of the mutant Glut4 species and the e¡ect of insulin. Clones expressing the indicated mutant were stimulated
with or without insulin (1 WM for 30 min) then subjected to subcellular fraction by di¡erential centrifugation as outlined. 25 Wg of plasma
membrane or LDM fractions were analysed by immunoblotting with anti-Glut3 antibodies to detect the heterologously expressed mutant Glut4
species. Representative immunoblots are shown in A with quanti¢cation of three experiments of this type presented in B.
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presented here is less than that of TAG-1. In all that follows,
we will compare the mutant cell lines with that of TAG-1.
Fig. 2 shows the subcellular distribution of TAG-1 (the
highest expressing TAG clone generated in this study) with
representative clones of AQE, EAE and EQA. Fig. 2A shows
representative immunoblots (quanti¢ed in Fig. 2B) in which
anti-Glut3 antibodies were used to analyse the subcellular
distribution and e¡ects of insulin on the di¡erent mutant
transporters. AQE characteristically exhibited a modest in-
crease in plasma membrane levels of the Glut4 mutant in
the absence of insulin compared to TAG-1 control cells
(Fig. 2B). The plasma membrane/LDM ratios of the di¡erent
mutants are presented in Table 2.
The ability of insulin to redistribute AQE and EQA to the
plasma membrane was considerably impaired (Fig. 2A,B). By
contrast, both TAG-1 and EAE exhibited striking transloca-
tion to the plasma membrane after insulin treatment. To fur-
ther examine the ability of insulin to promote translocation of
these species, we utilised plasma membrane lawn assays as a
second independent assay of insulin-stimulated translocation,
and compared the ability of insulin to stimulate mutant Glut4
translocation with the insulin-stimulated translocation of en-
dogenous IRAP/vp165. The data are presented in Fig. 3 and
further show that both AQE and EQA exhibit reduced insu-
lin-stimulated translocation to the cell surface.
One possible explanation for the decreased translocation of
AQE and EQA compared to TAG-1 is that they have failed to
gain access to the proposed Glut4 storage vesicles. In order to
address this, we performed endosome ablation analysis of
these cell lines to estimate the extent of localisation of each
of the mutants to the transferrin receptor-positive endosomal
system. By loading cells with Tf-HRP and performing DAB
cytochemistry þ hydrogen peroxide, we determined the extent
of localisation of the di¡erent mutants to the recycling endo-
somal compartment [24]. The results of this analysis are pre-
sented in Fig. 4. Both AQE and EQA exhibit signi¢cantly
greater susceptibility to Tf-HRP ablation than either TAG-1
or EAE, suggesting that a greater fraction of AQE and EQA
populate the transferrin receptor-positive recycling endosomal
system than is the case for TAG-1 or EAE.
4. Discussion
The molecular features that determine the unique intracel-
lular distribution and insulin-responsive behaviour of Glut4
have been studied using a range of experimental systems.
Although at least two regions of the protein have been impli-
cated in both internalisation and sub-endosomal tra⁄cking,
the sequences that dictate the tra⁄cking of Glut4 to the
unique insulin-responsive compartment remain controversial
(see [11,14] for discussion of this point). Here, we have studied
the role of three amino acids, Glu-491, Gln-492 and Glu-493,
located adjacent to the LeuLeu internalisation motif in the
Glut4 C-terminus. Mutation of Glu-491 and Glu-493 to ala-
nine resulted in a marked decrease in the ability of insulin to
promote translocation of these species to the plasma mem-
brane. Moreover, these mutations rendered the expressed mu-
tant Glut4 more susceptible to endosomal ablation, consistent
with these mutants residing primarily in endosomal compart-
ments. By contrast, mutation of Gln-492 to alanine had little
e¡ect on any parameter assayed in this study. At a minimum,
these studies establish an important role for these residues in
the subcellular tra⁄cking of Glut4 in this cell type.
Based upon the studies reported here, it is not possible to
Table 2
PM/LDM ratio of the mutant proteins
PM/LDM ratio
Glut4 0.16
TAG-1 0.15 þ 0.08
AQE 0.41 þ 0.10*
EAE 0.21 þ 0.06
EQA 0.12 þ 0.12
The PM/LDM ratio was determined from immunoblots such as
those presented in Fig. 2 for basal (unstimulated) cells. The data for
wild-type Glut4 were from [11,20]. *Signi¢cant increase compared
to TAG-1 (P6 0.05).
Fig. 3. Insulin-stimulated translocation of the mutant Glut4 species.
As an independent assay of translocation, mutant Glut4 species
were studied in plasma membrane lawns prepared from basal (3)
or insulin-stimulated insulin (+) (1 WM for 15 min) cells and stained
with anti-Glut3 or anti-vp165/IRAP. Shown are the data from a
representative experiment, each column is the mean of the intensity
of staining in 10 areas of three di¡erent coverslips, presented as
mean þ S.D. The experiment was repeated with similar results.
A: Anti-Glut3 results. B: Anti-vp165/IRAP results from the same
experiment. PM Glut3 (Glut4) levels refers to the relative level of
TAG Glut4 expressed at the cell surface under the conditions
shown.
FEBS 24132 15-9-00
D.L. Cope et al./FEBS Letters 481 (2000) 261^265264
draw ¢rm conclusions regarding the e¡ect of the mutation on
speci¢c aspects of the Glut4 tra⁄cking itinerary. It may be
speculated that the Glu-491CAla mutation may have exerted
a modest e¡ect on internalisation of the transporter, based
upon an apparent increase in the PM/LDM ratio of this par-
ticular mutant. However, the inability of the Glut3 epitope tag
to allow e⁄cient immunoprecipitation has precluded a de-
tailed analysis in this regard.
The fact that both the Glu-491CAla and Glu-493CAla
mutants exhibit increased susceptibility to endosome ablation
argues that an increased fraction of these mutants are co-
localised with transferrin receptors than is the case for the
endogenous protein (or TAG-1). This may re£ect either a
reduced rate of entry into the Glut4 storage vesicles, a reduced
ability of the mutants to be retained in these vesicles, or alter-
natively could re£ect a quite distinct pattern of intracellular
tra⁄cking of these mutants compared to endogenous Glut4.
The inability of the Glut3 epitope tag to allow e¡ective im-
munolocalisation has precluded detailed testing of these pos-
sibilities.
These caveats notwithstanding, our data are consistent with
an important role of Glu-491 and Glu-493 in the intracellular
tra⁄cking itinerary of Glut4 in insulin-sensitive 3T3-L1 adi-
pocytes. Whether these residues function in tandem with
known motifs, such as the adjacent LeuLeu region [11,14]
or the newly described targeting sequence located within TEL-
EYLGP (residues 498^505) [20] remains to be determined.
Given that this latter motif has been shown to play a key
role in targeting to the Glut4 storage vesicles/insulin-respon-
sive compartment, we favour a model in which Glu-491 and
Glu-493 modulate presently unde¢ned aspects of TGN/endo-
somal tra⁄cking rather than directly controlling tra⁄cking to
the specialised compartment.
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Fig. 4. Endosomal ablation of mutant Glut4 species. The distribu-
tion of the mutant Glut4 species within the endosomal system was
studied by endosomal ablation. To this end, duplicate plates of cells
were loaded with Tf-HRP to fully equilibrate the recycling endoso-
mal compartment. Both plates were then incubated with DAB in
the presence (test) or absence (control) of hydrogen peroxide. Perox-
ide acts as an electron donor which in the presence of HRP trans-
fers an electron to the DAB and thus generates a highly reactive
cross-linking species in the lumen of the endosomal compartment.
After this treatment, cells were washed and LDM fractions prepared
and immunoblotted for the presence of TAG Glut4. The extent of
ablation was de¢ned as the decrease in the immunoreactivity of
anti-Glut3 between these conditions. A: Representative immunoblot
with each of the cell lines studied. B: Quanti¢cation of three experi-
ments of this type, in which the mean value of three separate ex-
periments ( þ S.D.) is presented.
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